Watch HEPA. Know when insiders buy.
One email the day a filing lands. Free.
HEPA
Hepion Pharmaceuticals, Inc.
0.07
−0.01 −12.66%
USD · close Sep 16
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $6.2MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$3.2MNET CASH $13.7M52W 0.04 – 0.09SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose HEPA in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
KI Holdings Ltd.10.2%
“The Reporting Person acquired the securities for investment purposes. The Reporting Person intends to review its investment in the Issuer on a continuing basis. Depending upon market conditions, the Issuer's business, financial condition, prospects, general economic conditions and other factors deem…”
Kenneth Rickel5.7%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.